Your browser doesn't support javascript.
loading
Degradation of atrial natriuretic factor in mouse blood in vitro and in vivo: role of enkephalinase (EC 3.4.24.11).
Gros, C; Souque, A; Schwartz, J C.
Affiliation
  • Gros C; Unité de Neurobiologie et Pharmacologie, (U. 109) de l'INSERM Centre Paul Broca, Paris, France.
Neuropeptides ; 17(1): 1-5, 1990 Sep.
Article in En | MEDLINE | ID: mdl-2148814
ABSTRACT
The half-life of 125I-ANF (99-126) in mouse blood in vivo, evaluated after HPLC analysis, was approximately 0.5 min. This value was nearly doubled in mice pretreated with sinorphan, an enkephalinase inhibitor. 125I-ANF is also hydrolyzed by mouse blood in vitro but its half-life is much longer and only marginally modified by an enkephalinase inhibitor. Hence, although the peptidase is present in blood plasma and cells, its rate-limiting participation in the clearance of the hormone in vivo does not occur at the blood level.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Neprilysin / Atrial Natriuretic Factor Limits: Animals Language: En Journal: Neuropeptides Year: 1990 Document type: Article Affiliation country: Francia
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Neprilysin / Atrial Natriuretic Factor Limits: Animals Language: En Journal: Neuropeptides Year: 1990 Document type: Article Affiliation country: Francia